Fabricius Eva-Maria, Wildner Gustav-Paul, Kruse-Boitschenko Ute, Hoffmeister Bodo, Goodman Simon L, Raguse Jan-Dirk
Clinic for Oral and Maxillofacial Surgery, Campus Virchow Hospital Charité-Universitätsmedizin;
Exp Ther Med. 2011 Jan;2(1):9-19. doi: 10.3892/etm.2010.171. Epub 2010 Dec 2.
Integrins mediate the interaction of cells with the extracellular matrix and are believed to be involved in tumor cell survival and metastasis, and in tumor angiogenesis. We used immunohistochemistry of fresh-frozen human tumor tissues to analyze the presence of integrins αvβ3, αvβ5 and α5β1, which are believed to be involved in tumor growth and migration, together with integrin ligands, vitronectin, osteopontin, fibronectin and fibrinogen, in human oral squamous cell carcinomas. Samples of squamous cell carcinomas and control tissues from patients without cancer undergoing oral or maxillofacial surgery were frozen in liquid nitrogen within 30 min of removal. Frozen sections were prepared, and the presence of integrins or ligands was visualized using standard immunohistochemistry (APAAP) with a blinded evaluation. Comparison of samples from the 40 oral cancer patients and the 20 controls revealed increased staining in tumors compared with the controls, and staining was demonstrated for αvβ3 in endothelia. αvβ5 staining was increased in the tumor samples, but this was associated with increased expression in stroma rather than in endothelia. Modestly increased expression of α5β1 was observed in the tumor samples, and this was associated with tumor cells, endothelia and stroma. Expression of ligands for the integrins varied between tissue types, with increased fibrinogen and fibronectin expression in tumor endothelia. Confirmation of the presence of these integrins and their association with tumor cells, endothelia or stroma suggests their potential for these integrins in human oral tumors. Overall, the increased expression of integrins within tumors, particularly expression associated with endothelial cells, supports the principle of selective integrin blockade as a novel anticancer strategy.
整合素介导细胞与细胞外基质的相互作用,被认为参与肿瘤细胞的存活、转移以及肿瘤血管生成。我们采用新鲜冷冻的人类肿瘤组织免疫组化方法,分析整合素αvβ3、αvβ5和α5β1(据信参与肿瘤生长和迁移)以及整合素配体玻连蛋白、骨桥蛋白、纤连蛋白和纤维蛋白原在人类口腔鳞状细胞癌中的存在情况。来自接受口腔或颌面外科手术的无癌患者的鳞状细胞癌和对照组织样本在切除后30分钟内于液氮中冷冻。制备冷冻切片,使用标准免疫组化(碱性磷酸酶抗碱性磷酸酶法)可视化整合素或配体的存在,并进行盲法评估。对40例口腔癌患者和20例对照的样本进行比较,发现肿瘤中的染色较对照增加,且在内皮细胞中检测到αvβ3染色。肿瘤样本中αvβ5染色增加,但这与基质而非内皮细胞中的表达增加有关。在肿瘤样本中观察到α5β1表达适度增加,且这与肿瘤细胞、内皮细胞和基质有关。整合素配体的表达在不同组织类型之间有所不同,肿瘤内皮细胞中纤维蛋白原和纤连蛋白表达增加。这些整合素的存在及其与肿瘤细胞、内皮细胞或基质的关联得到证实,表明它们在人类口腔肿瘤中具有潜在作用。总体而言,肿瘤内整合素表达的增加,特别是与内皮细胞相关的表达,支持选择性整合素阻断作为一种新型抗癌策略的原理。